susceptibility of Pseudomonas aeruginosa to antibiotics in vitro, there are few on chemotherapy of experimental infections (5) . Polymyxin B and colistimethate, the two forms of polymyxin available for parenteral use in humans, have rarely been directly compared in mouse protection tests on P. aeruginosa. The aminoglycosides have seldom been compared with the polymyxins on P. aeruginosa in vivo.
The purpose of this study was to determine the activity of gentamicin, tobramycin, polymyxin B, and colistimethate on six strains of P. aeruginosa in the mouse protection tests.
MATERIALS AND METHODS The methods were generally those previously described (3) . Important changes will be noted.
Antibiotics. Tobramycin sulfate was supplied by Eli Lilly and Co. Gentamicin, polymyxin B, and sodium colistimethate were purchased from the University Hospital Pharmacy. Antibiotic dilutions were freshly prepared, and unused portions were discarded.
Bacteria. A group of 13 strains of P. aeruginosa were obtained from the Clinical Microbiology Laboratory of the University Hospital. All strains were isolated from blood culture between July 1973 to June 1974. Nine strains were discarded from the study. Five strains were resistant in vitro to gentamicin, and four strains had low virulence for mice.
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recent clinical isolates. Strain 41501 was characterized in a publication (11) and entered in the American Type Culture Collection (14) . Strain PA-103, a gift of P. V. Liu, produces exotoxin A and has been maintained in his laboratory for over ten years (10) . The Clinical Microbiology Laboratory of the University Hospital performed agar diffusion antibiotic susceptibility tests by the standard methods (12, 17) .
For mouse protection tests, the following method of culture was adopted because it gave reproducibly viruleint cultures. Typical colonies from agar plates were inoculated into 5 ml of brain-heart infusion broth (Baltimore Biological Laboratories, Baltimore, Md.), and the broth suspension was incubated 18 h at 37 C. A 0.5-ml sample was inoculated into 5 ml of brain-heart infusion broth, and the suspension was incubated for an additional 24 h at 37 C. Viable cell counts were about 3 x 109 ml.
Immunotype. This was determined with typing sera supplied by H. B. Devlin (7) .
Virluence. Virulence of broth cultures was established by injecting groups of mice intraperitoneally (i.p.) with 0.2 ml of serial 10-fold dilutions of broth cultures. Results were analyzed by Reed-Muench method (13) and expressed as mean infectious dose per milliliter (ID,dml).
Mouse protection tests. Mice were infected i.p. with 0.2 ml of bacterial suspension and for most studies were given single graded doses of antibiotics 1 h later. Animals were observed for 48 h. Data were analyzed by Spearman-Karber technique with the aid of a Wang computer (6) . The virulence of the inoculum was determined with each test by inoculating groups of mice i.p. with serial dilutions of the culture. Experiments with inocula that were too high or too low were discarded.
RESULTS
Antibiotic susceptibility, immunotype, and virulence of the six strains of P. aeruginosa in the study are shown in Table 1 . All strains were classified as susceptible by agar diffusion tests to gentamicin, tobramycin, polymyxin B, and colistin. The virulence of strain PA-103 for mice was considerably greater than that of the other five strains.
To test for toxins in the original inoculum, bacterial suspensions of all six strains were made free of living bacteria by heat (3 min in a boiling water bath) or by micropore filtration with a 0.22-jsm filter. There were no deaths among groups of mice injected i.p. with 0.2 ml of the treated suspensions.
To determine the influence of the size of the bacterial inoculum on the mean effective dose (ED,0) of antibiotics in the mouse protection test, groups of mice were infected i.p. with three different inocula of Pseudomonas PA-103 and were treated 1 h later with single graded doses of antibiotic given subcutaneously (s.c.; Table 2 ). A 10-fold increase in the bacterial inoculum produced a fourfold rise in the ED50 for gentamicin or tobramycin. There was no change in ED50 for polymyxin B.
To determine the influence of second and third doses of antibiotic on the ED50, groups of mice were infected i.p. with 5 ID,0 of (1) . In several studies, the inoculum was set at 107 organisms without regard to virulence (18) (19) (20) .
In another report, the inoculum was defined as a certain dilution of a broth culture without regard to virulence (16 
